Vaxcyte PCVX
NASDAQ PCVX
$56.33 -0.57 (-1.00%)
As of: Oct 1, 2026 · 2:16 PM EDT

Vaxcyte (PCVX) Depreciation & Amortization (CF) (2019 - 2026)

Updated

Vaxcyte's Depreciation & Amortization (CF) was $3 million in Q2 2026, up 4.3% from $2.88 million a year earlier and up 1.9% from the prior quarter.

Analysis

Vaxcyte (PCVX) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Vaxcyte's Depreciation & Amortization (CF) was $16.51 million through Jun 30, 2026, up 57.4% year-over-year; for FY2025, it came in at $16.4 million, up 134.1% from FY2024.

  • Depreciation & Amortization (CF) has now increased for seven consecutive years, with a five-year compound annual growth rate of 63.5% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $7 million in FY2024 (+121.9%), $3.16 million in FY2023 (+11.4%), $2.83 million in FY2022 (+57.4%) and $1.8 million in FY2021 (+28.1%).
  • Quarterly Depreciation & Amortization (CF) has moved between $459,000 (Q4 2021) and $7.5 million (Q4 2025) over five years.
  • Compared with a year earlier, Depreciation & Amortization (CF) was higher in seven of the last eight quarters, with growth averaging 111.3%.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q4 2024 (growth of 222.5%); the worst was Q4 2023 (a decline of 7.4%).
  • Per Business Quant data, PCVX's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $2.95 million (Q1 2026), $7.5 million (Q4 2025) and $3.06 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Vaxcyte 8.24 Bn 8.24 Bn - 3.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.00 Mn
Mar 31, 2026 2.95 Mn
Dec 31, 2025 7.50 Mn
Sep 30, 2025 3.06 Mn
Jun 30, 2025 2.88 Mn
Mar 31, 2025 2.96 Mn
Dec 31, 2024 2.86 Mn
Sep 30, 2024 1.79 Mn
Jun 30, 2024 1.35 Mn
Mar 31, 2024 999,000.00
Dec 31, 2023 888,000.00
Sep 30, 2023 806,000.00
Jun 30, 2023 750,000.00
Mar 31, 2023 712,000.00
Dec 31, 2022 959,000.00
Sep 30, 2022 684,000.00
Jun 30, 2022 609,000.00
Mar 31, 2022 582,000.00
Dec 31, 2021 459,000.00
Sep 30, 2021 510,000.00
API Access

Vaxcyte Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=PCVX&period=max&api_key=YOUR_API_KEY